• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10623
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Ischemia (1942); Vascular Dissection (3160)
Event Date 12/18/2021
Event Type  Injury  
Event Description
It was reported that a dissection occurred.Vascular access was obtained via the radial artery.A percutaneous transluminal coronary angioplasty was performed on a moderately tortuous and moderately calcified left anterior descending artery (lad).A 4.00 x 38 synergy ii drug eluting stent was deployed in the lad.Following deployment, a distal edge dissection was noted in the distal part of the stent.To cover the edge dissection, another 4.00 x 38 synergy was deployed distal to the first stent, overlapping it, and covered the edge dissection.The procedure was successfully completed, and the patient was reported to be stable.
 
Event Description
It was reported that a dissection occurred.Vascular access was obtained via the radial artery.A percutaneous transluminal coronary angioplasty was performed on a moderately tortuous and moderately calcified left anterior descending artery (lad).A 4.00 x 38 synergy ii drug eluting stent was deployed in the lad.Following deployment, a distal edge dissection was noted in the distal part of the stent.To cover the edge dissection, another 4.00 x 38 synergy was deployed distal to the first stent, overlapping it, and covered the edge dissection.The procedure was successfully completed, and the patient was reported to be stable.It was further reported that the lesion was predilated with a 3x8 semi compliant balloon.The 4x38 synergy stent was deployed at 12 atmospheres for around 4 to 6 seconds.Post dilation was performed with a non compliant balloon at 18 atmospheres, and dissection occurred during post dilation.The dissection was flow limiting.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key13184133
MDR Text Key283490735
Report Number2134265-2021-16529
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)Y
Reporter Country CodeIN
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 01/19/2022
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received01/06/2022
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date02/24/2023
Device Model Number10623
Device Catalogue Number10623
Device Lot Number0026926514
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received01/17/2022
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured02/24/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-